Coherus Oncology, Inc. Common Stock
CHRS
CHRS
188 hedge funds and large institutions have $1.08B invested in Coherus Oncology, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 81 increasing their positions, 58 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
-17
Holders Change %
-8.29%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
21
Increased
81
Reduced
58
Closed
38
Calls
$1.54M
Puts
$1.77M
Net Calls
-$228K
Net Calls Change
+$522K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$84.3M |
| 2 |
BlackRock
New York
|
$166M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$12.2M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
$62.3M |
| 5 |
State Street
Boston,
Massachusetts
|
$70.2M |
